Purui Ophthalmology (301239.SZ) released its half-year financial results, with a net profit attributable to the parent company of 14.67 million yuan, a decrease of 66.12%.

Intelligent Finance APP news, Prui Ophthalmology (301239.SZ) released its 2025 semi-annual report. The company's operating income was 1.459 billion yuan, an increase of 2.74% year-on-year. Net profit attributable to shareholders of the listed company was 14.6675 million yuan, a decrease of 66.12% year-on-year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 20.7809 million yuan, a decrease of 54.14% year-on-year. Basic earnings per share were 0.0985 yuan.